biological therapeutics
biological therapeutics
Revolutionizing mRNA: A Breakthrough in Biologics!
🌟 Discover how Ginkgo Bioworks and TriLink BioTechnologies are revolutionizing mRNA manufacturing for better vaccines and therapeutics! 🚀🔬💡
Is Your Biotech Project at Risk of Titre Issues?
🚨 Neglecting optimal manufacturing strains for biological therapeutics can derail projects and increase costs. Prioritize strain development for success! 💡💊📈
Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!
📢 German CDMO Wacker Biotech opens €100m RNA manufacturing site, creating 100 jobs and expanding expertise in RNA active ingredients. 💪🌍
Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient
🧪 Quick production of therapeutics and vaccines using a disease-agnostic platform approach. 📊 Improved mRNA yields in just two hours. 🖥️ Real-time process monitoring and control. 💉 Billions of vaccine doses produced using a platform process. 🧫 Efficient and cost-effective allogeneic cell therapies. 🌐 Scalable, monitored, and controlled manufacturing of advanced therapies and vaccines. 💡 Future perspective: reducing costs and manufacturing risk with platform-based iPSC production.
Breakthrough: Affordable Customised Albumin Revolutionizes Therapeutics
📅 January 22, 2024. Demand for animal-free recombinant albumin has led to high prices, limiting access to affordable vaccines and monoclonal antibodies. New technologies are increasing production and expanding its use beyond therapeutics to skincare. Albumin is widely used in diagnostics, medical devices, and regenerative medicine. Patent protections and limited suppliers have created shortages. Lower quality albumin is affordable but presents manufacturing and regulatory issues. Customised strains of baker's yeast are now enabling the production of high-quality, affordable albumin. This could accelerate research and unleash the full potential of albumin. ✨🧪💉🌿🔬💊📈
